Literature DB >> 25447307

Differential contribution of key metabolic substrates and cellular oxygen in HIF signalling.

Alexander V Zhdanov1, Alicia H C Waters2, Anna V Golubeva3, Dmitri B Papkovsky2.   

Abstract

Changes in availability and utilisation of O2 and metabolic substrates are common in ischemia and cancer. We examined effects of substrate deprivation on HIF signalling in PC12 cells exposed to different atmospheric O2. Upon 2-4h moderate hypoxia, HIF-α protein levels were dictated by the availability of glutamine and glucose, essential for deep cell deoxygenation and glycolytic ATP flux. Nuclear accumulation of HIF-1α dramatically decreased upon inhibition of glutaminolysis or glutamine deprivation. Elevation of HIF-2α levels was transcription-independent and associated with the activation of Akt and Erk1/2. Upon 2h anoxia, HIF-2α levels strongly correlated with cellular ATP, produced exclusively via glycolysis. Without glucose, HIF signalling was suppressed, giving way to other regulators of cell adaptation to energy crisis, e.g. AMPK. Consequently, viability of cells deprived of O2 and glucose decreased upon inhibition of AMPK with dorsomorphin. The capacity of cells to accumulate HIF-2α decreased after 24h glucose deprivation. This effect, associated with increased AMPKα phosphorylation, was sensitive to dorsomorphin. In chronically hypoxic cells, glutamine played no major role in HIF-2α accumulation, which became mainly glucose-dependent. Overall, the availability of O2 and metabolic substrates intricately regulates HIF signalling by affecting cell oxygenation, ATP levels and pathways involved in production of HIF-α.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer cell; Cellular oxygen; Glutaminolysis; Glycolysis; HIF signalling; Metabolic substrates

Mesh:

Substances:

Year:  2014        PMID: 25447307     DOI: 10.1016/j.yexcr.2014.10.005

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  10 in total

Review 1.  From Krebs to clinic: glutamine metabolism to cancer therapy.

Authors:  Brian J Altman; Zachary E Stine; Chi V Dang
Journal:  Nat Rev Cancer       Date:  2016-07-29       Impact factor: 60.716

Review 2.  Immunometabolism: A new target for improving cancer immunotherapy.

Authors:  Chunqing Guo; Shixian Chen; Wenjie Liu; Yibao Ma; Juan Li; Paul B Fisher; Xianjun Fang; Xiang-Yang Wang
Journal:  Adv Cancer Res       Date:  2019-04-17       Impact factor: 6.242

3.  Ghrelin rapidly elevates protein synthesis in vitro by employing the rpS6K-eEF2K-eEF2 signalling axis.

Authors:  Alexander V Zhdanov; Anna V Golubeva; Martina M Yordanova; Dmitry E Andreev; Ana Paula Ventura-Silva; Harriet Schellekens; Pavel V Baranov; John F Cryan; Dmitri B Papkovsky
Journal:  Cell Mol Life Sci       Date:  2022-07-16       Impact factor: 9.207

4.  Quantitative analysis of mucosal oxygenation using ex vivo imaging of healthy and inflamed mammalian colon tissue.

Authors:  Alexander V Zhdanov; Irina A Okkelman; Anna V Golubeva; Barbara Doerr; Niall P Hyland; Silvia Melgar; Fergus Shanahan; John F Cryan; Dmitri B Papkovsky
Journal:  Cell Mol Life Sci       Date:  2016-08-10       Impact factor: 9.261

5.  Oxygen and glucose deprivation induces widespread alterations in mRNA translation within 20 minutes.

Authors:  Dmitry E Andreev; Patrick B F O'Connor; Alexander V Zhdanov; Ruslan I Dmitriev; Ivan N Shatsky; Dmitri B Papkovsky; Pavel V Baranov
Journal:  Genome Biol       Date:  2015-05-06       Impact factor: 13.583

6.  Hypoxia induces triglycerides accumulation in prostate cancer cells and extracellular vesicles supporting growth and invasiveness following reoxygenation.

Authors:  Isabel R Schlaepfer; Dhanya K Nambiar; Anand Ramteke; Rahul Kumar; Deepanshi Dhar; Chapla Agarwal; Bryan Bergman; Michael Graner; Paul Maroni; Rana P Singh; Rajesh Agarwal; Gagan Deep
Journal:  Oncotarget       Date:  2015-09-08

7.  Combined analysis of gene expression and genome binding profiles identified potential therapeutic targets of ciclopirox in Ewing sarcoma.

Authors:  Baisheng Yuan; Wei Ji; Haipeng Xia; Jianmin Li
Journal:  Mol Med Rep       Date:  2018-01-10       Impact factor: 2.952

Review 8.  Oncogenic regulation of tumor metabolic reprogramming.

Authors:  Míriam Tarrado-Castellarnau; Pedro de Atauri; Marta Cascante
Journal:  Oncotarget       Date:  2016-09-20

9.  Characterization of dysregulated glutamine metabolism in human glioma tissue with 1H NMR.

Authors:  Selin Ekici; Benjamin B Risk; Stewart G Neill; Hui-Kuo Shu; Candace C Fleischer
Journal:  Sci Rep       Date:  2020-11-24       Impact factor: 4.379

Review 10.  Clinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinoma.

Authors:  Alexander W Eckert; Claudia Wickenhauser; Paul C Salins; Matthias Kappler; Juergen Bukur; Barbara Seliger
Journal:  J Transl Med       Date:  2016-04-05       Impact factor: 5.531

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.